NCT07811817

Brief Summary

we compare the effect of cutting heart nerves in one group of patients with open heart surgery and other group without cutting oh development of disturbance of heart beat after surgery

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
560

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Oct 2025Nov 2026

Study Start

First participant enrolled

October 20, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

September 4, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 10, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Expected
Last Updated

September 10, 2026

Status Verified

September 1, 2026

Enrollment Period

11 months

First QC Date

September 4, 2026

Last Update Submit

September 4, 2026

Conditions

Keywords

sympathetic cardiac denervationpost cardiac surgery atrial fibrillation

Outcome Measures

Primary Outcomes (2)

  • Incidence of overall Post operative atrial fibrillation

    defined as any telemetry-documented or 12-lead ECG-confirmed episode of atrial fibrillation, atrial flutter, or atrial tachycardia lasting ≥30 continuous seconds through POD 7 or hospital discharge defined as any telemetry-documented or 12-lead ECG-confirmed episode of atrial fibrillation, atrial flutter, or atrial tachycardia lasting ≥30 continuous seconds through POD 7 or hospital discharge (whichever comes first

    7th Post operative day or hospital discharge (whichever comes first).

  • Incidence of persistent Post operative atrial fibrillation

    (duration \>24 continuous hours or requiring urgent chemical/electrical cardioversion due to hemodynamic instability).

    3 months posoperative

Study Arms (2)

sympathetic cardiac denervation

ACTIVE COMPARATOR

Before CPB initiation or during aortic cross-clamping, surgical denervation will be performed via meticulous blunt and sharp dissection. Target sites include \[e.g., complete transection/resection of the ligament of Marshall, fat pad mobilization at Waterston's groove, and epicardial neural pathway division\].

Procedure: cardiac sympathetic denervation

control

OTHER

Standard open-heart surgery without additional epicardial or fat pad dissection.

Procedure: Standard open-heart surgery without additional epicardial or fat pad dissection.

Interventions

Before CPB initiation or during aortic cross-clamping, surgical denervation will be performed via meticulous blunt and sharp dissection. Target sites include \[e.g., complete transection/resection of the ligament of Marshall, fat pad mobilization at Waterston's groove, and epicardial neural pathway division\].

sympathetic cardiac denervation

Standard open-heart surgery without additional epicardial or fat pad dissection.

control

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years scheduled for elective open-heart surgery via median sternotomy (CABG, valve repair/replacement, or combined procedures).

You may not qualify if:

  • Preoperative permanent pacemaker or ICD.
  • Emergency surgery, active endocarditis, or severe hemodynamic instability.
  • Concomitant planned surgical ablation (e.g., Cox-Maze procedure) or left atrial appendage occlusion.
  • Preoperative use of antiarrhythmic drugs (AADs) other than beta-blockers within 5 half-lives of surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amr Tawfek

Zagazig, Sharqia Province, 44519, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor of cardiothoracic surgery

Study Record Dates

First Submitted

September 4, 2026

First Posted

September 10, 2026

Study Start

October 20, 2025

Primary Completion

September 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

September 10, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations